热门资讯> 正文
Foghorn Therapeutics任命Kristian Humer为首席财务官
2024-04-16 19:25
- Foghorn Therapeutics (NASDAQ:FHTX) on Tuesday announced that Kristian Humer would join the company as CFO.
- Humer joins Foghorn with over 14 years of diversified financial strategy and business development experience in the life science industry and more than 20 years of experience in the financial industry, the company added.
- Prior to joining Foghorn, Humer most recently held executive roles at Viridian Therapeutics, where he successfully led financial strategy and business development as the chief financial officer and chief business officer.
- Source: Press Release
More on Foghorn Therapeutics
- Foghorn says Eli Lilly picked lung cancer candidate for further studies
- Seeking Alpha’s Quant Rating on Foghorn Therapeutics
- Historical earnings data for Foghorn Therapeutics
- Financial information for Foghorn Therapeutics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
